Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Analgesic Efficacy and Pharmacokinetic-pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 After Impacted Mandibular Third Molar Extraction - A Double-blind, Randomised, Placebo-controlled Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05508594

Organisation Name: Cessatech A/S

Overal Status: Recruiting

Start Date: September 5, 2022

Last Update: October 3, 2022

Lead Sponsor: Cessatech A/S

Brief Summary: A randomised, double-blind, parallel-group, study comparing the analgesic effect of intranasal CT001 to intranasal sufentanil, intranasal ketamine or placebo for treatment of acute pain in adults undergoing surgical removal of an impacted mandibular third molar, where bone removal is judged to be needed.

Conditions:
  • Pain


Total execution time in seconds: 0.30572581291199